Sökning: WFRF:(Hasvold Pal)
> (2018) >
Long-term cardiovas...
Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease results from a nationwide Swedish study
-
Hasvold, Pal (författare)
-
Nordanstig, Joakim, 1973- (författare)
-
Kragsterman, Björn (författare)
-
visa fler...
-
Kristensen, Thomas (författare)
-
Falkenberg, Marten (författare)
-
Johansson, Saga (författare)
-
Thuresson, Marcus (författare)
-
Sigvant, Birgitta (författare)
-
visa färre...
-
(utgivare)
- OXFORD UNIV PRESS, 2018
- 2018
- Engelska.
-
Ingår i: European Heart Journal - Quality of Care and Clinical Outcomes. - 2058-5225. ; 4:1, 10-17
Abstract
Ämnesord
Stäng
- Aims: Data on long-term healthcare costs of patients with peripheral artery disease (PAD) is limited, and the aim of this study was to investigate healthcare costs for PAD patients at a nationwide level. Methods and results: A cohort study including all incident patients diagnosed with PAD in the Swedish National Patient Register between 2006-2014, and linked to cause of death-and prescribed drug registers. Mean per-patient annual healthcare costs (2015 Euros (sic)) (hospitalisations and out-patient visits) were divided into cardiovascular (CV), lower limb and non-CV related cost. Results were stratified by high and low CV risk. The study included 66,189 patients, with 221,953 observation-years. Mean total healthcare costs were (sic)6,577, of which 26% was CV-related ((sic)1,710), during the year prior to the PAD diagnosis. First year after PAD diagnosis, healthcare costs were (sic)12,549, of which (sic)3,824 (30%) was CV-related and (sic)3,201 (26%) lower limb related. Highrisk CV patients had a higher annual total healthcare and CV related costs compared to low risk CV patients during follow-up ((sic)7,439 and (sic)1,442 versus (sic)4,063 and (sic)838). Annual lower limb procedure costs were (sic)728 in the PAD population, with lower limb revascularisations as key cost driver ((sic)474). Conclusion: Non-CV related hospitalizations and outpatient visits were the largest cost contributors for PAD patients. There is a substantial increase in healthcare costs in the first year after being diagnosed with PAD, driven by PAD follow-up and lower limb related procedures. Among the CV-related costs, hospitalisations and outpatient visits related to PAD represented the largest costs.
Ämnesord
- Medical and Health Sciences (hsv)
- Medicin och hälsovetenskap (hsv)
Nyckelord
- Nationwide register data
- peripheral artery disease
- healthcare resource use
- healthcare costs
Hitta via bibliotek
Till lärosätets databas